Literature DB >> 6135390

Purinergic neurotransmission and neuromodulation.

C Su.   

Abstract

Conflicting views abound on the peripheral neurotransmitter and neuromodulator roles of purine compounds. Substantial organ- and species-related variations have become apparent. There is, however, a body of compelling evidence for such roles, if not so broad and ubiquitous as those envisioned (7) for the central nervous system. The variations may in part be attributable to the neuroeffector synaptic geometry. The transmitter concentration found at the postsynaptic membrane drops precipitously with increase in the synaptic cleft (85). Where the cleft is narrow, a purine may serve as the primary or sole transmitter (purinergic nerve) and presynaptic modulator. Alternatively, from nonpurinergic (e.g. adrenergic) nerves a purine may be released, possibly ATP by exocytosis, to act as a cotransmitter. It may also serve as pre- and post-synaptic modulator, potentially with a contribution from postsynaptic release (Figure 1). The purine could conceivably diffuse and affect other varicosities. Where the cleft is wide, the postsynaptic concentration of the neurogenic purine may be too low to permit a transmitter or postsynaptic modulator function. The concentration of the nonpurine transmitter may also be insufficient to elicit a significant postsynaptic purine release. The neuronally released purine may, however, presynaptically exert inhibition of transmitter release much as in a narrow cleft. It seems, therefore, that the origin of synaptic purines and their function, be it transmitter, cotransmitter, or modulator, are dictated at least in part by the characteristics of the purine pools, purinergic receptors, and synaptic configuration, which await further assessment.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6135390     DOI: 10.1146/annurev.pa.23.040183.002145

Source DB:  PubMed          Journal:  Annu Rev Pharmacol Toxicol        ISSN: 0362-1642            Impact factor:   13.820


  23 in total

1.  Quantitative analysis of depolarization-induced ATP release from mouse brain synaptosomes: external calcium dependent and independent processes.

Authors:  J L Fiedler; H B Pollard; E Rojas
Journal:  J Membr Biol       Date:  1992-04       Impact factor: 1.843

2.  Ca2+ influx through ATP-gated channels increments [Ca2+]i and inactivates ICa in myocytes from guinea-pig urinary bladder.

Authors:  P Schneider; H H Hopp; G Isenberg
Journal:  J Physiol       Date:  1991       Impact factor: 5.182

3.  Adenosine agonists reduce voltage-dependent calcium conductance of mouse sensory neurones in cell culture.

Authors:  R L MacDonald; J H Skerritt; M A Werz
Journal:  J Physiol       Date:  1986-01       Impact factor: 5.182

4.  Characterization of prejunctional purinoceptors on adrenergic nerves of the rat caudal artery.

Authors:  K Shinozuka; R A Bjur; D P Westfall
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-09       Impact factor: 3.000

5.  Absence of P2-purinoceptors in hippocampal pathways.

Authors:  T W Stone; N J Cusack
Journal:  Br J Pharmacol       Date:  1989-06       Impact factor: 8.739

6.  Inhibitory adenosine A1-receptors on rat locus coeruleus neurones. An intracellular electrophysiological study.

Authors:  J T Regenold; P Illes
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-03       Impact factor: 3.000

7.  Purine metabolite inosine is an adrenergic neurotrophic substance for cultured chicken sympathetic neurons.

Authors:  A D Zurn; K Q Do
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

8.  Dual control by ATP and acetylcholine of inwardly rectifying K+ channels in bovine atrial cells.

Authors:  D D Friel; B P Bean
Journal:  Pflugers Arch       Date:  1990-03       Impact factor: 3.657

9.  The activity of phosphorothioate analogues of ATP in various smooth muscle systems.

Authors:  T W Stone
Journal:  Br J Pharmacol       Date:  1985-01       Impact factor: 8.739

10.  Purinoceptor-mediated modulation by endogenous and exogenous agonists of stimulation-evoked [3H]noradrenaline release on rat iris.

Authors:  H Fuder; A Brink; M Meincke; U Tauber
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-04       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.